Mon, Mar 2, 2015, 6:39 AM EST - U.S. Markets open in 2 hrs 51 mins


% | $
Quotes you view appear here for quick access.

Dynavax Technologies Corporation Message Board

  • jimbotool jimbotool Feb 14, 2013 1:25 PM Flag

    FDA Panel Vote Revisited

    The actual transcript of November 15th meeting is posted on, all 177 pages of it,at page 170 the members who voted NO are asked to explain their reason. The first guy says he wanted a larger trial size of 8-10,000 patients, read how each one 'agrees' with whatever was said before them before adding their own comment(if any). Including the NO's who seemingly favored approval for the higher risk patients, to lessen safety issue. The very last comment came from Dr Gellin ,from CDC, IMO another 'SOFT'(see p.168) NO vote , I'm now quoting Gellin "we have to be realistic that if you double or triple the number in the trial you are STILL looking for rare things to happen, and they are unlikely to light up if you have a study population of eight, 10, 15 thousand, if you are looking for one in a we start looking at these new adjuvants there is going to be a lot of scrutiny about that experience. So that doesn't mean that we need to go slowly, but we need to go methodically." Reading that transcript, I found a lot more reasons in to approval.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
17.60+0.10(+0.57%)Feb 27 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Aruba Networks, Inc.
NASDAQFri, Feb 27, 2015 4:00 PM EST